Isoptine

Verapamil Hydrochloride, the active ingredient in Isoptine, is a calcium channel blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure, chest pain due to angina, and certain cardiac rhythm disturbances in adult patients.

GNH USA supplies Isoptine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to EU and other markets. Customers benefit from reliable lead times and comprehensive technical support.

Isoptine, a calcium channel blocker, is indicated for several cardiovascular conditions.

Hypertension: Reduces systemic vascular resistance to lower blood pressure. Angina pectoris: Improves myocardial oxygen supply by decreasing cardiac workload. Cardiac arrhythmias: Controls ventricular rate in supraventricular tachyarrhythmias.

Verapamil Hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Constipation: Reduced gastrointestinal motility. - Dizziness: Transient light‑headedness. - Headache: Mild to moderate intensity. - Flushing: Warm sensation and skin reddening. - Peripheral edema: Swelling of lower limbs. - Nausea: Stomach upset.

Serious or Rare Side Effects: - Bradycardia: Markedly slowed heart rate. - Hypotension: Significant drop in blood pressure. - Atrioventricular block: Impaired conduction between atria and ventricles. - Heart failure exacerbation: Worsening of existing cardiac insufficiency. - Severe allergic reaction: Anaphylaxis or angioedema. - Liver enzyme elevation: Hepatotoxicity signs.

Before initiating Isoptine, clinicians should consider several safety measures to minimize risk.

- Blood pressure monitoring: Check baseline and periodic readings. - Cardiac function assessment: Evaluate for existing heart block or heart failure. - Concomitant beta‑blocker use: Adjust dose to avoid excessive bradycardia. - Hepatic impairment: Use lower doses and monitor liver tests. - Severe hypotension: Contraindicated in patients with markedly low blood pressure. - Store at room temperature: Keep in the original container, protect from moisture and light.

Verapamil Hydrochloride interacts with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Beta‑blockers: Additive negative chronotropic effect may cause severe bradycardia. - Digoxin: Increases serum digoxin concentrations, raising toxicity risk. - Diltiazem: Combined calcium channel blockade can lead to profound hypotension. - Strong CYP3A4 inhibitors (e.g., ketoconazole): Elevate verapamil levels, increasing adverse effect potential.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): Reduce verapamil exposure, diminishing efficacy. - ACE inhibitors or ARBs: May enhance antihypertensive effect, requiring blood pressure monitoring. - Statins metabolized by CYP3A4 (e.g., simvastatin): Increased risk of statin‑related muscle toxicity.